Randy Ban - 04 Jan 2022 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Commercial Officer
Signature
/s/ Richard Buchholz, as Attorney-in-Fact for Randy Ban
Issuer symbol
INSP
Transactions as of
04 Jan 2022
Net transactions value
-$2,470,805
Form type
4
Filing time
06 Jan 2022, 15:15:33 UTC
Previous filing
28 Dec 2021
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $10,422 +5,035 +1893% $2.07* 5,301 04 Jan 2022 Direct F1
transaction INSP Common Stock Options Exercise $1,636 +1,740 +33% $0.9400* 7,041 04 Jan 2022 Direct
transaction INSP Common Stock Sale $1,626,000 -6,775 -96% $240.00 266 04 Jan 2022 Direct F2
transaction INSP Common Stock Options Exercise $7,311 +3,532 +1328% $2.07* 3,798 05 Jan 2022 Direct
transaction INSP Common Stock Sale $864,174 -3,532 -93% $244.67 266 05 Jan 2022 Direct F2
holding INSP Common Stock 167 04 Jan 2022 By son
holding INSP Common Stock 166 04 Jan 2022 By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -5,035 -59% $0.000000 3,532 04 Jan 2022 Common Stock 5,035 $2.07 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -1,740 -24% $0.000000 5,533 04 Jan 2022 Common Stock 1,740 $0.9400 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -3,532 -100% $0.000000* 0 05 Jan 2022 Common Stock 3,532 $2.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 18 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on December 28, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 5, 2021.
F3 The option is fully vested and exercisable.